Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format.

Dengue fever is a major health concern worldwide. The virus encoded non-structural protein 3 (NS3) is a multifunctional protein endowed with protease, helicase, nucleoside triphosphatase (NTPase) and RNA 5' triphosphatase (RTPase) activities. Helicase activity of NS3 catalyzes the unwinding of double stranded polynucleotides by utilizing the energy released from ATP hydrolysis. As this activity is essential for replication, NS3 helicase represents an attractive drug target for developing a dengue antiviral drug. Here, we report fluorescence based molecular beacon helicase assay using a duplex RNA substrate that contains a fluorophore on the 5' end and a quencher on the 3' end of one of the strands. The assay was optimized with respect to several parameters and adapted to 384-well high-throughput screening format, with an average Z' factor of 0.65. Assay validation with a small diverse set library of 1600 compounds identified, suramin as a significant inhibitor of the helicase activity of NS3. Helicase activity deficient NS3 K199A was used in a counter-screen to identify compounds interfering with the assay. Suramin inhibited DENV (dengue virus) NS3 helicase activity with a Ki of 0.75±0.03μM as a non-competitive inhibitor. The molecular beacon helicase assay together with the counter screen and suramin as a tool compound can be used to identify novel inhibitors of DENV helicase.

[1]  L. Romano,et al.  Benzo[a]pyrene-DNA adducts inhibit translocation by the gene 4 protein of bacteriophage T7. , 1989, The Journal of biological chemistry.

[2]  Wolfgang Jahnke,et al.  Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein , 2008, The EMBO journal.

[3]  D. Earnshaw,et al.  Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening , 1999, Journal of biomolecular screening.

[4]  James K. Tamura,et al.  RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria , 1993, Journal of virology.

[5]  M. Bolognesi,et al.  Structure-based inhibition of Norovirus RNA-dependent RNA polymerases. , 2012, Journal of molecular biology.

[6]  Alicia M. Hanson,et al.  Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays , 2012, Nucleic acids research.

[7]  Dmitri I Svergun,et al.  A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target , 2011, Proceedings of the National Academy of Sciences.

[8]  F. Hawking Suramin: with special reference to onchocerciasis. , 1978, Advances in pharmacology and chemotherapy.

[9]  M. Bolognesi,et al.  Structural Bases of Norovirus RNA Dependent RNA Polymerase Inhibition by Novel Suramin-Related Compounds , 2014, PloS one.

[10]  C. Richardson,et al.  The gene 4 protein of bacteriophage T7. Characterization of helicase activity. , 1983, The Journal of biological chemistry.

[11]  M. Sivaraja,et al.  High-throughput screening assay for helicase enzymes. , 1998, Analytical biochemistry.

[12]  R. Harrison,et al.  Development of a novel helicase assay using electrochemiluminescence. , 2001, Analytical biochemistry.

[13]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[14]  G. Kadaré,et al.  Virus-encoded RNA helicases , 1997, Journal of virology.

[15]  C. Rice,et al.  Molecular biology of flaviviruses. , 2003, Advances in virus research.

[16]  K. Morita,et al.  Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein , 2000, FEBS letters.

[17]  D. Wigley,et al.  Modularity and Specialization in Superfamily 1 and 2 Helicases , 2002, Journal of bacteriology.

[18]  H. Schmitz,et al.  Purification and Characterization of West Nile Virus Nucleoside Triphosphatase (NTPase)/Helicase: Evidence for Dissociation of the NTPase and Helicase Activities of the Enzyme , 2001, Journal of Virology.

[19]  S. Benkovic,et al.  A fluorescence-based assay for monitoring helicase activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Mitra,et al.  Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective. , 2013, Recent patents on anti-infective drug discovery.

[21]  D. Earnshaw,et al.  FlashPlate Scintillation Proximity Assays for Characterization and Screening of DNA Polymerase, Primase, and Helicase Activities , 2001, Journal of biomolecular screening.

[22]  S. Vasudevan,et al.  Crystal structure of the NS3 protease-helicase from dengue virus , 2008 .

[23]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[24]  G. Maga,et al.  The RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core. , 2004, Virology.

[25]  J. Cohen,et al.  Update on New Antivirals Under Development for the Treatment of Double‐Stranded DNA Virus Infections , 2010, Clinical pharmacology and therapeutics.